As diabetes care continues to be a crucial focus, innovative treatments are emerging . Retatrutide, Tirzepatide, and Semaglutide represent a exciting advancement in incretin mimetic medications. While all https://bookmarkrange.com/story24121816/the-new-drug-vs-tirzepatide-vs-semaglutide-a-head-to-head-analysis